Context Matters Blog Part III: 4 Market Access Assumptions Misleading Biotechs

Part III: Global market access planning begins after phase III clinical trials A founding principle for Context Matters is the connection between clinical trial design with regulatory and reimbursement decisions-the earlier you start thinking about market access the better. Aubagio® offers a great example of the connection of clinical trial design with reimbursement and regulatory decisions.